Table 1 Changes in serum markers in patients with different treatment time to remission
Remission time < 6 months (n = 19) | Remission time ≥ 6 months (n = 31) | p-value | |
|---|---|---|---|
T0-Estradiol, pg/mL | 105.2 ± 187.2 | 53.1 ± 83.9 | 0.322 |
T0-FSH, IU/L | 5.5 ± 2.3 | 5.3 ± 3.1 | 0.831 |
T0-LH, IU/L | 3.0 ± 2.1 | 3.8 ± 3.2 | 0.494 |
T0-T, nmol/L | 1.0 ± 0.6 | 0.9 ± 0.7 | 0.672 |
T0-PRL, ng/mL | 20.3 ± 11.2 | 21.0 ± 9.6 | 0.437 |
T0-HOMA-IR | 2.2 ± 1.3 | 4.2 ± 2.0 | 0.004 |
T1-HOMA-IR | 2.4 ± 1.5 | 3.6 ± 3.7 | 0.311 |
T2-HOMA-IR | 2.7 ± 1.8 | 4.0 ± 2.9 | 0.185 |
T1 vs. T0-HOMA-IR | − 12% | − 39% | 0.049 |
T2 vs. T0-HOMA-IR | 25% | − 44% | 0.020 |
T0-HbA1c, % | 5.7 ± 0.4 | 5.6 ± 0.4 | 0.922 |
T0-FT4, pmol/L | 16.4 ± 2.8 | 16.8 ± 1.9 | 0.688 |
T0-TSH, uIU/mL | 2.1 ± 1.7 | 2.2 ± 0.9 | 0.864 |